United States Nuclear Plant Services Market

United States (U.S.) Nuclear Plant Services Market Segmentation by Plant Type (Pressured, Boiling, and Pressurized Heavy Water Plants, Gas-Cooled Plants, and Others); by Services (Plant Commissioning, Operations Management, Laboratory Management, Safety & Environmental Services, Emergency Response Services, Modernization, Decontamination & Decommissioning, Quality Management, and Others) – Demand Analysis & Opportunity Outlook 2019-2028

Buy Now
Report ID: 3035 | Published On: Feb 01, 2022
  1. Introduction
    • Market Definition
    • Market Segmentation
    • Product Overview
  2. Assumptions and Acronyms
  3. Research Methodology
  4. Research Process
    • Primary Research
    • Manufacturers
    • Distributors
    • End Users
    • Secondary Research
    • Market Size Estimation
  5. Executive Summary - Global Advanced Therapy Medicinal Products Market
  6. Analysis of Market Dynamics
  7. Drivers
  8. Trends
  9. Key Market Opportunities for Business Growth
  10. Major Roadblocks for the Market Growth
  11. Regulatory & Standard Landscape
  12. Value Chain Analysis
  13. Potential ATMP Treatment Analysis
  14. Pricing Analysis of Global Advanced Therapy Medicinal Products Market
  15. Use Case Analysis
  16. Pipeline Analysis
  17. Analysis on the Manufacturing Process
  18. Analysis of COVID-19 Impact on the Global Advanced Therapy Medicinal Products Market
  19. Analysis of End-User Market Share of Global Advanced Therapy Medicinal Products
  20. Competitive Positioning
  21. Competitive Landscape
  22. Market Share Analysis of Major Players (%), 2021
  23. Competitive Benchmarking
  24. Novartis AG.
  25. Takeda Pharmaceutical Company Limited
  26. Gilead Sciences, Inc.
  27. Bluebird Bio, Inc
  28. BioMarin Pharmaceutical Inc
  29. Vericel Corporation
  30. Mallinckrodt Pharmaceuticals
  31. UniQure N.V.
  32. JCR Pharmaceuticals Co., Ltd.
  33. Spark Therapeutics, Inc. (Parent Company: Roche)
  34. Kolon TissueGene, Inc.
  35. Global Advanced Therapy Medicinal Products Market Outlook
  36. By Value (USD million)
  37. By Product
  38. CAR-T Therapy, 2021-2031F (USD million)
  39. Gene Therapy, 2021-2031F (USD million)
  40. Cell Therapy, 2021-2031F (USD million)
  41. Tissue Engineered Product, 2021-2031F (USD million)
  42. By Disease
  43. Oncology, 2021-2031F (USD million)
  44. Genetic Disorders, 2021-2031F (USD million)
  45. CNS, 2021-2031F (USD million)
  46. Dermatology, 2021-2031F (USD million)
  47. Others, 2021-2031F (USD million)
  48. By End-User
  49. Hospitals & Clinics, 2021-2031F (USD million)
  50. Research & Academic Institutes, 2021-2031F (USD million)
  51. Global Advanced Therapy Medicinal Products Market by Region
  52. North America, 2021-2031F (USD million)
  53. Europe, 2021-2031F (USD million)
  54. Asia-Pacific, 2021-2031F (USD million)
  55. Latin America, 2021-2031F (USD million)
  56. Middle East & Africa, 2021-2031F (USD million)
  57. North America Advanced Therapy Medicinal Products Market Outlook
  58. By Value (USD million)
  59. By Product
  60. CAR-T Therapy, 2021-2031F (USD million
  61. Gene Therapy, 2021-2031F (USD million)
  62. Cell Therapy, 2021-2031F (USD million)
  63. Tissue Engineered Product, 2021-2031F (USD million)
  64. By Disease
  65. Oncology, 2021-2031F (USD million)
  66. Genetic Disorders, 2021-2031F (USD million)
  67. CNS, 2021-2031F (USD million)
  68. Dermatology, 2021-2031F (USD million)
  69. Others, 2021-2031F (USD million)
  70. By End-User
  71. Hospitals & Clinics, 2021-2031F (USD million)
  72. Research & Academic Institutes, 2021-2031F (USD million)
  73. By Country
  74. US, 2021-2031F (USD million)
  75. Canada, 2021-2031F (USD million)
  76. Europe Advanced Therapy Medicinal Products Market Outlook
  77. By Product
  78. By Disease
  79. By End User
  80. By Country
  81. UK, 2021-2031F (USD Million)
  82. Germany, 2021-2031F (USD Million)
  83. France, 2021-2031F (USD Million)
  84. Italy, 2021-2031F (USD Million)
  85. Spain, 2021-2031F (USD Million)
  86. Russia, 2021-2031F (USD Million)
  87. Netherlands, 2021-2031F (USD Million)
  88. Rest of Europe, 2021-2031F (USD Million)
  89. Asia Pacific Advanced Therapy Medicinal Products Market Outlook
  90. By Product
  91. By Disease
  92. By End User
  93. By Country
  94. China, 2021-2031F (USD Million)
  95. India, 2021-2031F (USD Million)
  96. Japan, 2021-2031F (USD Million)
  97. South Korea, 2021-2031F (USD Million)
  98. Singapore, 2021-2031F (USD Million)
  99. Australia, 2021-2031F (USD Million)
  100. Rest of Asia-Pacific, 2021-2031F (USD Million)
  101. Latin America Advanced Therapy Medicinal Products Market Outlook
  102. By Product
  103. By Disease
  104. By End User
  105. By Country
  106. Brazil, 2021-2031F (USD Million)
  107. Argentina, 2021-2031F (USD Million)
  108. Mexico, 2021-2031F (USD Million)
  109. Rest of Latin America, 2021-2031F (USD Million)
  110. Middle East & Africa Advanced Therapy Medicinal Products Market Outlook
  111. By Product
  112. By Disease
  113. By End User
  114. By Country
  115. GCC, 2021-2031F (USD Million)
  116. Israel, 2021-2031F (USD Million)
  117. South Africa, 2021-2031F (USD Million)
  118. Rest of Middle East & Africa, 2021-2031F (USD Million)

Preview Analysis

Request Insights
Inflation and Looming Recession to Haunt Businesses:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.


In The News


U.S. Nuclear Plant Services Market Highlights 2019-2028

The U.S. nuclear plant services market is anticipated to grow with a CAGR of 3.65% during the forecast period, i.e., 2021-2028. The growth of the market in the nation can be attributed to the rising demand for electricity in the United States, backed by the increasing population and urbanization, along with the growing decommissioning activities of nuclear power plants in the nation. The nation had around 96 commercial nuclear reactors operating by the end of 2019, along with close to 60 nuclear power plants in its twenty-nine states. Further, the nation produced approximately 19% of electricity via the nuclear power plants in 2019. This production is further stated to grow by about 8% by the end of 2030. The prime benefit of producing electricity from nuclear power plants is to lower the carbon dioxide emissions, which usually is higher when electricity is produced from coal or gas. On the other hand, the nation recorded to have around 40 reactors which are completely shut down and require maintenance. Further, by 2040, close to 90 nuclear facilities are anticipated to be decommissioned, raising the need for maintenance of these facilities. Such factors are anticipated to drive the growth of the market during the forecast period. The U.S. nuclear plant services market recorded a value of USD 19,776.4 Million in the year 2019 and is further projected to touch USD 26,630.5 Million by the end of 2028.

U.S. Nuclear Plant Services Market Graph


Growth Drivers and Challenges Impacting the Growth of the U.S. Nuclear Plant Services Market

Growth Drivers

  • Rising Demand for Electricity in the United States
  • Growing Decommissioning Activities of Nuclear Plants in the Nation

Challenges

  • Increasing Costs Associated with the Construction of Nuclear Plants
  • Lack of Waste Management System for Nuclear Plants


U.S. Nuclear Plant Services Market Segmentation Synopsis

The U.S. nuclear plant services market is segmented by plant type into pressured water plant, boiling water plant, pressurized heavy water plant, gas-cooled plant, and others. Among these segments, the pressured water plant segment registered the largest market share in the year 2019 and is projected to attain a value of USD 13577.06 Million by the end of 2021. Pressured water plants have a major advantage over other plant-types. These plants require less power and is comparatively easy to operate. The core of the reactor contains less fissile material, which further decreases the probability of any additional nuclear fission. As a result, these plants are safer and can be easily controlled. Till date, the nation has around 69 pressurized water nuclear reactor plants that are licensed by the regulatory commission.CLICK TO DOWNLOAD SAMPLE REPORT

The market is also segmented on the basis of service into plant commissioning, operations management, laboratory management, safety & environmental services, emergency response services, modernization, decontamination & decommissioning, quality management, and others. Among these segments, the plant commissioning segment recorded the largest market share of 48.65% in the year 2019. Alternatively, the decontamination & decommissioning segment is projected to grow with the highest CAGR of 4.85% throughout the forecast period.


U.S. Nuclear Plant Services Market Graph
Get more information on this report: Request Sample PDF

Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the U.S. nuclear plant services market that are included in our report are GE Hitachi Nuclear Energy (GEH), AECOM, Bechtel Corporation, BHI Energy, Westinghouse Electric Company LLC, EnergySolutions, Mitsubishi Nuclear Energy Systems, Inc., and others.


Key Questions Answered in the Report

1) What are the major factors driving the growth of the United States nuclear plant services market?

Ans: Growing demand for electricity in the nation, along with the increasing number of decommissioning activities of nuclear plants, are some of the major factors driving the market growth.

2) What would be the CAGR of United States nuclear plant services market over the forecast period?

Ans: The market is anticipated to attain a CAGR of 3.65% over the forecast period, i.e., 2021-2029.

3) What are the challenges affecting the United States nuclear plant services market growth?

Ans: Rising costs for the construction of nuclear plants and the unavailability of waste management systems for these types of plants are some of the major factors estimated to act as barriers to the growth of the market.

5) Who are the major players dominating the United States nuclear plant services market?

Ans: The major companies in the market are GE Hitachi Nuclear Energy (GEH), AECOM, Bechtel Corporation, BHI Energy, Westinghouse Electric Company LLC, EnergySolutions, Mitsubishi Nuclear Energy Systems, Inc., and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from segments, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the U.S. nuclear plant services market?

Ans: The U.S. nuclear plant services market is segmented by plant type, and by services.

8) Which segment under plant type segment is projected to hold the dominating share in the U.S. nuclear plant services market?

Ans: The pressured water plant segment is projected to hold the largest market share by the end of 2028. The segment is further anticipated to attain a value of USD 13577.06 Million by the end of 2021.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Submit RFP    Buy Now Download Research Report Sample